{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-025027","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.918382+00:00","generated_at":"2026-05-31T11:40:26.190635+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Puma Biotechnology wins patent suit vs AstraZeneca; $107.5M jury award upheld in bench trial","bullets":["Jury found Tagrisso infringes Wyeth's patents; damages of $107.5M for past infringement through Dec 31, 2023.","Bench trial on equitable claims ruled in Wyeth's favor; all AstraZeneca defenses rejected.","Puma maintains contractual rights to recover monetary damages under license with Pfizer.","Post-trial motions pending; AstraZeneca seeks new trial, Wyeth seeks supplemental damages and ongoing royalties."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-025027","json":"https://secwatch.observer/filing/0001437749-24-025027.json","markdown":"https://secwatch.observer/filing/0001437749-24-025027.md","text":"https://secwatch.observer/filing/0001437749-24-025027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924025027/0001437749-24-025027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924025027/pbyi20240806_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:40:26.190635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}